Skip to main content
. 2021 Oct 1;8:715728. doi: 10.3389/fmolb.2021.715728

FIGURE 5.

FIGURE 5

The expression and correlation between immune checkpoints in high and low-risk patients in the TARGET and ICGC cohorts. (A) CD276 (B) HHLA2 (C) TNFRSF18 (D) TNFSF9 (E) LGALS9.